The Purpose Is To Develop An Action Plan That Creates Such A Capital Structure That Will Upgradesand Standardize The Quality of Business Analysis

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 9

ABSTRACT

A project work is a mandatory requirement


f o r t h e B u s i n e s s M a n a g e me n t Pr og ra mme . Th i s ty p e
o f s tu dy ai ms a t e xp os i ng th e young prospective executive to
the actual business
world.T h i s p r o j e c t g i v e s m e k n o w l e d g e a b o u t t h e c a
p i t a l s t r u c t u r e a n d theory analysis.Financing decisions involve
raising funds for the firm.It is concerned with formulation and
designing of capital structure or leverage. The most crucial decision
of any company is involved in theformulation of its appropriate
capital structure. The best design or structure of the capital of a
company helps the management to
achievei t s u l t i m a t e o b j e c t i v e s o f m i n i m i s i n g
o v e r a l l c o s t o f c a p i t a l , maximising profitability
and also maximising the value of the firm.organization. It is very
effective way to judge a companys cash flow prospects, as cash is
like blood life for any company.The report initially begins with the
company profile, followed by
thed e t a i l e d a n a l y s i s o f c o m p a n y , l i k e b u s i n e s s e
s o f t h e c o m p a n y , products offered by the company,
financials of the company,
etcT h e r e p o r t i n v o l v e s a l o t o f r e s e a r c h t o u n d e r s t a
n d w h a t e x a c t l y c ap i ta l st ru c tu r e o f t he c o mpa ny
s ho ul d b e. th a t s , w hy c o mp a n ie s require appropriate capital
structure.
T he p ur po se i s t o d ev e l op an action plan that creates such
a capital structure that will upgradesand standardize the quality
of business analysis.

COMPANY PROFILE
A

company empowered by one mission to place itself on the


world map. An enterprise propelled by one force-that synergizes its
energies tocharter unexplored markets. Organizations fuelled by
one dream-to transformcompetition into opportunity.
Ranbaxy Laboratories Ltd. was incorporated in June 1961, in the
name of M/SLEPITIT RANBAXY LABORATORIES LTD and it
commenced its businessin MARCH 1962, in technical and financial
collaboration with an internationalcompany named LEPTIT SPA,
MILAN, ITALY.Ranbaxy Laboratories Pvt. Ltd. merged with Leptit
Ranbaxy Laboratories Pvt.Ltd. in 1962 Ranbaxy and company also
merged with this company in 1966.The collaboration arrangement
with M/S LEPTIT was terminated in 1966; after which Indian nationals
acquired the entire share capital of the company.Therefore the word
Leptit was removed from the name of the company.
Thena me is kn ow n a s R A N B A X Y L A B O R ATOR I E S L I M
I T E D . In 19 73 t he company issued shares to the general public and
became a full fledged PUBLICLIMITED
COMPANY.Tod ay, R a nb a xy ha s e me rge d a s a L e a d in g P h a
r m a c e u t i c a l C o m p a n y o n t h e I n d i a n f i r ma me n t
, w it h t he se co nd la rge s t ma r ke t share and enjoys an enviable
reputation for itshigh standard of ethics and quality around itscore
strength of anti-infective, it has producednew brands in emerging
therapeutic areas like cardiovascular, central nervous

system and nutritional. supporting this expansion, the company has


invested inworld class manufacturing infrastructure that leverages Indias
comparative costadvantage and skilled manpower, while delivering international
quality.The companys drive for Internationalism is guided by the well
planned brandstrategy that covers some of the world emerging markets like
China, cis, CentralE u ro pe a nd L a t in Ame r i c a . It s po si t i on
t od ay is in le ag ue of th e Top Ten Pharmaceutical
companies of three world an decent ranking as the
eleventhl a r g e s t c o m p a n y i n t h e i n t e r n a t i o n a l g e n
e r i c s s p a c e i s t h e r e s o u n d i n g endorsement of its strategic
mind.It is clear that for a long time, the dominant share of revenues of
the companywould continue to come from the ever expanding global generics
market. Hencethe intent of Ranbaxy mission is to achieve a sustained
growth rate through thecontinuous pursuit of innovation phase one trials for
pervasion, a compound for treating prosthetic males have been
completed. Phase 1 trials with clafrinast, anasthma compound is an
important step towards research based value creation.This company also had
success with Ciplofloxacine, an ingenious form, createdthrough the
novel drug delivery systems research. As the demand of the
bulk drugs inside the country and abroad was increasingly rapidly a
new, plant wasset up at Toansa near Ropar in 1987. This was a higher
capacity plant designedto cater to the present and future needs,
initially antibiotics like Ampicillin,Trihydrate and Doxycycline were
manufactured.Later, on the other drugs like Cephalexin monohydrate and
Ranitidine were also prepared. The plant at Toansa was designed to meet
the stringent standards set by the Food and Drug Administration
(FDA) of U.S.A. This plant has beenapproved by FDA and this
will open up American and other newer markets for Ranbaxys
productsAt present Ranbaxy have four plants for the manufacture of
bulk drugs two atMohali, one at Dewas (M.P) AND Another at Toansa
near ROPAR. At present,Ranbaxy is the second most Indian company
engaged in the manufacturing of Pharmaceuticals, Bulk Drugs and Fine
Chemicals.RANBAXYs vast range of highly pure laboratory reagent
and chemicals
enjoya p l a c e o f p r i d e i n t h e m a r k e t . I T t r e n d s , h a s r
e b u i l t A s a s t e p t o w a r d s leveraging information for value creation

using its information backbone aroundan ERP application, along the focus on
reengineering several business
processesaround the internet and has putting
place business solutions that challengeexisting ways of doing
Business. The undying spirit of the companys humanassets and their
intensive competitive and entrepreneurial energy has played a
GJ-IMT,MOHALI ANUJ KUMAR SRIVASTAVA Page
5
of
94

great part in transforming the company into a multicultural and multiracial


team.Today, Ranbaxy is the largest exporter accounting for
12% of the industryexports pharmaceutical substance and dosages
forms to over 50 countries withthe internationals sales comprising of 45%
of the total turnover.

VISION:
During the year 2002, the company has evolved a 10-year vision till
2012, for sustaining significant growth consistent with its mission to
be an internationalresearch based Pharmaceutical Company,
under the rubric
Vision Garuda

,with increasing emphasis on


Novel Drug Delivery Systems Research (DDR)

.In licensing and out licensing, relationship with other important


pharmaceuticale nt i t ie s , e xp a n si on of ma nu f a c t ur i ng fa c i li t i
e s b ot h i n I nd ia an d st r a te g ic overseas locations, revamping of
organizational structures to cater to the wider and more dispersed span
of operations, and streamlining and standardizing the business
processes through out the global organization, are other areas
thatreceive focus and attention of management on priority.

You might also like